Regulatory

“The Hemp Access and Consumer Safety Act” was previously proposed in 2021.

The July 27th hearing was called by the House Oversight and Accountability Committee’s Subcommittee on Health Care and Financial Services.

On July 17, FDA declined a request by U.S. Representative Jeff Duncan (R–SC) to hold a public hearing to clarify the agency’s recent stance that nicotinamide mononucleotide (NMN) is not allowed in dietary supplements.

Major supplement industry associations support the new bipartisan Dietary Supplements Access Act.

Here’s what brands need to know about the FDA’s Modernization of Cosmetics Regulation Act.

The Thailand Food and Drug Administration (TFDA) approved the algae-derived beta-glucan ingredient in food supplements for humans at a 375-mg daily dose.

Blood sugar–management supplements are capitalizing on growing consumer demand.

USDA’s Strengthening Organic Enforcement rule was finalized earlier this year. Here’s what companies need to know.

The Brazilian Health Regulatory Agency (ANVISA) approved Probiokid for use in infants and children aged 3 months to 36 months.

KT-11’s safe use in food and drinks was evaluated by an independent Generally Recognized as Safe expert panel from regulatory consultant AIBMR Life Sciences.

The GRAS notification was compiled by South Korean firm OraTicx and regulatory services company GRAS Associates, a Nutrasource company.

The European Food Safety Authority (EFSA) confirmed BetaVia Pure’s safety for foods and supplements in the European Union.

According to a press release from the company, the petition asks the Agency “to address the mislabeling of dietary supplements and functional foods as ‘mushroom’ or containing ‘mushrooms’ when they contain other fungal parts, and do not contain ‘mushrooms’ as claimed, or fail to disclose added grain ingredients.”

Designed to help improve the quality of life for people with histamine intolerance, DAOgest is now available for sale in the European market.

Why FDA’s proposal to redefine “healthy” unsurprisingly isn’t as simple as it sounds.

The legislation, which has passed the state’s Assembly and Senate was introduced in April after Governor Kathy Hochul vetoed similar legislation in December 2022.

A recent review investigated the relationship between dietary supplements and eating disorders, finding no causal relationship between dietary supplement usage and the development of eating disorders.

Stefan M. Pasiakos, PhD, FACSM has been selected to be director of the National Institutes of Health (NIH) Office of Dietary Supplements. He will begin in his new role on July 16, 2023.

Here’s why the 2023 Farm Bill must clarify CBD’s legal status for the food, beverage, and supplement industries, writes Scott Mazza of Vitality CBD.

The Council for Responsible Nutrition wrote to FDA on May 4 urging the agency to consider all of the safety evidence for CBD supplements that supplement companies have so far submitted to the agency.

Australia’s Therapeutic Goods Administration (TGA) has added galactooligosaccharides (GOS) to its Permissible Ingredients Determination for listed complementary medicines in Australia, announced GOS ingredient supplier FrieslandCampina Ingredients.

The Council for Responsible Nutrition’s citizen petition asks FDA to “reconsider” how the agency has been invoking the FD&C Act’s drug preclusion clause to remove dietary supplement ingredients from the market.

The company says D-BHB can increase levels of blood ketones without requiring users to consume excess calories and fat associated with a typical low-carb diet.

Setria glutathione is an antioxidant ingredient that has been shown to support the immune system and overall health and wellness, the firm says.

Representative Jeff Duncan, a republican congressman representing South Carolina’s 3rd District, has sent a letter to the U.S. Food and Drug Administration’s Commissioner, Robert M. Califf, MD, asking the Agency to hold public hearing on NMN decision.

The paper summarizes the rationale for using proprietary blends in dietary supplements, how they are regulated and labeled, as well as the challenges this presents for researchers.

Industry advocates defend the safety record of melatonin and criticize the letter as misleading and ill-informed.

The review raises concerns about the potential toxicity of CBD but industry advocates contend that the research is misleading and outside of the scope of dietary supplement products.